OPIANT PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q3 2010 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2010 to Q1 2022.
  • Opiant Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$2.1M, a 223% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $1.93M.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$2.03M, a 150% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2019 was $4.06M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$2.1M -$3.82M -223% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $1.71M +$883K +106% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $830K +$2.28M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 -$1.45M -$3.65M -166% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $2.2M +$3.77M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 -$1.57M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q3 2012 -$206K +$317K +60.7% Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-20
Q3 2011 -$523K -$331K -172% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q3 2010 -$192K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.